Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Germany Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20063
20072
20085
20094
20104
20116
20122
20132
20143
20153
20162
20174
20188
20197
20201
20215
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion15
Bayer9
Bial - Portela C S.A.6
United Therapeutics6
University of Giessen4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
GlaxoSmithKline3
Heidelberg University3
Novartis Pharmaceuticals3
Gilead Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension69
Hypertension, Pulmonary26
Familial Primary Pulmonary Hypertension4
Hypertension2
Cardiovascular Diseases1
Connective Tissue Diseases1
Cryptogenic Organizing Pneumonia1
Eisenmenger Complex1
Hamman-Rich Syndrome1
Hypoxia1

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.